Back
Aclaris Therapeutics, Inc. 10K Form
Buy
81
ACRS
Aclaris Therapeutics, Inc.
Last Price:
$2.96
Seasonality Move:
43.1%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ACRS News And Ratings
See the #1 stock for the next 7 days that we like better than ACRS
ACRS Financial Statistics
Sales & Book Value
| Annual Sales: | $18.7M |
|---|---|
| Cash Flow: | $-11M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.11 |
| Price / Book: | 2.72 |
Profitability
| EPS (TTM): | -1.38140 |
|---|---|
| Net Income (TTM): | $-141.7M |
| Gross Margin: | $3.5M |
| Return on Equity: | -103.93% |
| Return on Assets: | -73.37% |
Aclaris Therapeutics, Inc. Earnings Forecast
Key Aclaris Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 11 years for ACRS is 18.49%.
-
The Selling, General & Administrative Expenses for ACRS have been equal to 118.61% of Gross Profit Margin.
-
The Research & Development expenses have been 171.40% of Revenue.
-
The Net Earning history of ACRS is -705.48% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 5 years.
Aclaris Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ACRS |
| CUSIP: | 00461U |
| Website: | aclaristx.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 3.92 |
| Quick Ratio: | 3.92 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ACRS Technical Analysis vs Fundamental Analysis
Buy
81
Aclaris Therapeutics, Inc. (ACRS)
is a Buy
Is Aclaris Therapeutics, Inc. a Buy or a Sell?
-
Aclaris Therapeutics, Inc. stock is rated a BuyThe current Aclaris Therapeutics, Inc. [ACRS] share price is $3.01. The Score for ACRS is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.